Role of platelet-activating factor and prostanoids in hemodynamic changes in rat experimental endotoxic shock

Japanese Journal of Pharmacology

Volumn 71, Issue 3, 1996, Pages 247-253

  Ebara, Tsuneyuki ^a   Miura, Katsuyuki ^a   Matsuura, Takeshi ^a   Imanishi, Masahito ^b   Yamano, Yoshiki ^a   Kim, Shokei ^a   Iwao, Hiroshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Cyclooxygenase; Endotoxin; Hemodynamics; Platelet activating factor

Indexed keywords

3 BROMO 5 [N PHENYL N [2 [[2 (1,2,3,4 TETRAHYDRO 2 ISOQUINOLYLCARBONYLOXY)ETHYL]CARBAMOYL]ETHYL]CARBAMOYL] 1 PROPYLPYRIDINIUM NITRATE; DOMITROBAN; ENDOTOXIN; IBUPROFEN; PROSTAGLANDIN ENDOPEROXIDE; PROSTANOID; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; HEART OUTPUT; HEART RATE; HEMOCONCENTRATION; HYPOTENSION; MALE; NONHUMAN; RAT; SEPTIC SHOCK; TACHYCARDIA; VASCULAR RESISTANCE;

EID: 0029787857     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.71.247     Document Type: Article

References (29)

1. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 328, 1471-1477 (1993)
2. Morrison DC and Ryan JL: Endotoxins and disease mechanisms. Annu Rev Med 38, 417-432 (1987)
3. Szabo C: Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 3, 2-32 (1995)
4. Yamanaka S, Iwao H, Yukimura T, Kim S and Miura K: Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock. Br J Pharmacol 110, 1501-1507 (1993)
5. Wise WC, Cook JA, Eller T and Halushka PV: Ibuprofen improves survival from endotoxic shock in the rat. J Pharmacol Exp Ther 215, 160-164 (1980)
6. Terashita Z, Imura Y, Nishikawa K and Sumida S: Is platelet activating factor (PAF) a mediator of endotoxin shock? Eur J Pharmacol 109, 257-261 (1985)
7. Kawamura M, Kitayoshi T, Terashita Z, Fujiwara S, Takatani M and Nishikawa K: Effects of TCV-309, a novel PAF antagonist, on circulatory shock and hematological abnormality induced by endotoxin in dogs. J Lipid Mediat Cell Signal 9, 255-265 (1994)
8. Toyofuku T, Kubo K, Kobayashi T and Kusama S: Effects of ONO-6240, a platelet-activating factor antagonist, on endotoxin shock in unanesthetized sheep. Prostaglandins 31, 271-281 (1986)
9. Siebeck M, Weipert J, Keser C, Kohl J, Spannagl M, Machleidt W and Schweiberer L: A triazolodiazepine platelet activating factor receptor antagonist (WEB 2086) reduces pulmonary dysfunction during endotoxin shock in swine. J Trauma 31, 942-949 (1991)
10. Gilbert RP: Mechanisms of the hemodynamic effects of endotoxin. Physiol Rev 40, 245-279 (1960)
11. Siren AL and Feuerstein G: Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. Am J Physiol 257, H25-H32 (1989)
12. Terashita Z, Takatani M, Nishikawa K: Pharmacological profile of TCV-309 - a potent PAF antagonist. J Lipid Medial 5, 183-185 (1992)
13. Terashita Z, Kawamura M, Takatani M, Tsushima S, Imura Y and Nishikawa K: Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. J Pharmacol Exp Ther 260, 748-755 (1992)
14. Szabo C, Wu CC, Mitchell JA, Gross SS, Thiemermann C and Vane JR: Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res 73, 991-999 (1993)
15. 2 receptor. Nature 349, 617-620 (1991)
16. Yamanaka S, Miura K, Yukimura T, Okumura M and Yamamoto K: Putative mechanism of hypotensive action of platelet-activating factor in dogs. Circ Res 70, 893-901 (1992)
17. Pugsley MK, Salari H and Walker MJ: Actions of platelet-activating factor on isolated rat hearts. Circ Shock 35, 207-214 (1991)
18. Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ and Wilson MF: Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock 17, 273-284 (1985)
19. Rabinovici R, Yue TL, Farhat M, Smith E3, Esser KM, Slivjak M and Feuerstein G: Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist. J Pharmacol Exp Ther 255, 256-263 (1990)
20. Qi M and Jones SB: Contribution of platelet activating factor to hemodynamic and sympathetic responses to bacterial endotoxin in conscious rats. Circ Shock 32, 153-163 (1990)
21. Doebber TW, Wu MS, Robbins JC, Choy BM, Chang MN and Shen TY: Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. Biochem Biophys Res Commun 127, 799-808 (1985)
22. Chang SW, Feddersen CO, Henson PM and Voelkel NF: Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 79, 1498-1509 (1987)
23. Ball HA, Cook JA, Wise WC and Halushka PV: Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock. Intensive Care Med 12, 116-126 (1986)
24. Cook JA, Wise WC and Halushka PV: Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency. J Clin Invest 65, 227-230 (1980)
25. Braquet P, Touqui L, Shen TY and Vargaftig BB: Perspectives in platelet-activating factor research. Pharmacol Rev 39, 97-145 (1987)
26. Chao W and Olson MS: Platelet-activating factor: receptors and signal transduction. Biochem J 292, 617-629 (1993)
27. Tempel GE, Cook JA, Wise WC, Halushka PV and Corral D: Improvement in organ blood flow by inhibition of thromboxane synthetase during experimental endotoxic shock in the rat. J Cardiovasc Pharmacol 8, 514-519 (1986)
28. Redl G, Abdi S, Traber LD, Nichols RJ, Flynn JT, Herndon DN and Traber DL: Inhibition of thromboxane synthesis reduces endotoxin-induced right ventricular failure in sheep. Crit Care Med 19, 1294-1302 (1991)
29. Kirton OC, Jones RC and Carvalho AC: Thromboxane and prostacyclin release after endotoxin infusion in the rat. Intensive Care Med 16, 436-440 (1990)